Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
MRVI
MRVI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MRVI News
Maravai LifeSciences Q4 2025 Earnings Call Highlights
Feb 26 2026
seekingalpha
Maravai LifeSciences Q4 Earnings Report Analysis
Feb 25 2026
seekingalpha
Maravai LifeSciences to Announce Q4 Earnings on February 25
Feb 24 2026
seekingalpha
Maravai to Announce Q4 and Full Year 2025 Financial Results
Feb 09 2026
Businesswire
Maravai to Announce Q4 and Full Year 2025 Results
Feb 09 2026
Newsfilter
Aptamer Licenses Optimer for Hot-Start PCR to Alphazyme, Securing Global Rights
Dec 23 2025
NASDAQ.COM
Insider Buying Update for Wednesday, October 12: AVTR, MRVI
Dec 10 2025
NASDAQ.COM
Post-Market Surge: Stoke Therapeutics, Alpha Tau Medical, and Compass Pathways Top Biotech Gainers
Dec 10 2025
NASDAQ.COM
Reminder: Bragar Eagel & Squire, P.C. Ongoing Investigation for Maravai Long-Term Shareholders
Oct 28 2025
Globenewswire
ETF Movers on Tuesday: FIG, ITB
Oct 07 2025
NASDAQ.COM
Investigation Notice: Bragar Eagel & Squire, P.C. Informs Long-Term Stockholders of Maravai LifeSciences Holdings, Inc. and Invites Investors to Reach Out to the Firm
Oct 01 2025
Globenewswire
ETF Movers on Friday: URA, FIG
Sep 19 2025
NASDAQ.COM
Bragar Eagel & Squire, P.C. Ongoing Investigation into Maravai LifeSciences Holdings, Inc. for Long-Term Stockholders; Investors Encouraged to Reach Out to the Firm
Sep 09 2025
Globenewswire
Maravai LifeSciences Holdings Q2 2025 Earnings Preview
Aug 10 2025
SeekingAlpha
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
Jul 28 2025
Newsfilter
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Jul 22 2025
Globenewswire
Show More News
